» Articles » PMID: 24224649

A Phase 2 Study of HQK-1001, an Oral Fetal Haemoglobin Inducer, in β-thalassaemia Intermedia

Overview
Journal Br J Haematol
Specialty Hematology
Date 2013 Nov 15
PMID 24224649
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Chonat S, Quinn C Adv Exp Med Biol. 2017; 1013:59-87.

PMID: 29127677 PMC: 5720159. DOI: 10.1007/978-1-4939-7299-9_3.


Evolution of hemoglobin loci and their regulatory elements.

Philipsen S, Hardison R Blood Cells Mol Dis. 2017; 70:2-12.

PMID: 28811072 PMC: 5807248. DOI: 10.1016/j.bcmd.2017.08.001.


Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.

Ng N, Ko C Int Sch Res Notices. 2016; 2014:123257.

PMID: 27350962 PMC: 4897541. DOI: 10.1155/2014/123257.


Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.

Chou Y, Chen R, Lai Z, Song J, Chao Y, Shen C Mol Cell Biol. 2015; 35(14):2541-53.

PMID: 25986606 PMC: 4475914. DOI: 10.1128/MCB.00035-15.

References
1.
Perrine S, Ginder G, Faller D, Dover G, Ikuta T, Witkowska H . A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993; 328(2):81-6. DOI: 10.1056/NEJM199301143280202. View

2.
Fucharoen S, Inati A, Siritanaratku N, Thein S, Wargin W, Koussa S . A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia. Br J Haematol. 2013; 161(4):587-93. PMC: 3970579. DOI: 10.1111/bjh.12304. View

3.
Bauer D, Kamran S, Orkin S . Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. Blood. 2012; 120(15):2945-53. PMC: 4467860. DOI: 10.1182/blood-2012-06-292078. View

4.
Thein S, Menzel S, Lathrop M, Garner C . Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009; 18(R2):R216-23. PMC: 2758709. DOI: 10.1093/hmg/ddp401. View

5.
Collins A, Pearson H, Giardina P, McDonagh K, Brusilow S, Dover G . Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood. 1995; 85(1):43-9. View